Browse grants

EXPLORE OPPORTUNITIES

Forecast grants in United States

Explore opportunities worth a look.

394 opportunities
US
Naval Engineering Education Consortium (NEEC) Broad Agency Announcement for Fiscal Year 2026NSWC Dahlgren · $450,000
US
Novel approaches to support therapeutic development in ultra-rare cancersFood and Drug Administration
US
OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not AllowedFood and Drug Administration · $250,000
US
Partnership Intermediary Agreement (PIA)Munitions Directorate
US
Providers Clinical Support System – UniversitiesSubstance Abuse and Mental Health Services Adminis · $5,000,000
US
REACHing Communities (REACH) Consortium (U01) Clinical Trials OptionalFood and Drug Administration · $3,000,000
US
Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing FacilitiesFood and Drug Administration · $3,000,000
US
Residential Treatment for Pregnant and Postpartum WomenSubstance Abuse and Mental Health Services Adminis · $12,000,000
US
Retail Food Safety Regulatory Association CollaborationFood and Drug Administration · $4,000,000
US
Retail Food Safety Regulatory Association Collaboration CAPFood and Drug Administration · $4,000,000
US
STARBASE Cherry PointNAVAIR
US
STARBASE Wright PattAir Force -- Research Lab
US
State Pilot Program for Treatment for Pregnant and Postpartum WomenSubstance Abuse and Mental Health Services Adminis · $2,800,000
US
Studies Addressing Rare Neurodegenerative Diseases including ALSFood and Drug Administration
US
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not AllowedFood and Drug Administration · $300,000
US
U.S. Embassy Cairo Public Diplomacy Section Annual Program StatementU.S. Mission to Egypt
US
U.S. Embassy The Hague PD Annual Program StatementU.S. Mission to the Netherlands · $25,000
US
USDA/USDOI Joint Fire Science Program (JFSP)Bureau of Land Management
US
Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not AllowedFood and Drug Administration · $300,000

Report an error

Sources: US Government work (public domain) · Source: Grants.gov